ArtVentive EOS Peripheral Vascular Enoluminal Occlusion system receives CE Mark certification

NewsGuard 100/100 Score
Jun 1 2013

ArtVentive Medical Group, Inc. (OTC Bulletin Board: AVTD) announced today that the Company has received its European CE Mark certification for the ArtVentive EOS™ Peripheral Vascular Enoluminal Occlusion system.

“This is a very significant achievement in the Company's history as it moves toward commercialization and its planned launch into the European markets”

"This is a very significant achievement in the Company's history as it moves toward commercialization and its planned launch into the European markets," stated Dr. Leon Rudakov, President and CTO. "The CE Mark also paves the way to facilitate approvals for the ArtVentive EOS™ device internationally in meeting with the Company's global mandate," stated Jim Graham, CEO and Chairman.

SOURCE ArtVentive Medical Group, Inc.

Posted in: Device / Technology News

Tags: , , , ,

Comments (0)

Suggested Reading

Vitamin D deficiency linked to increased dementia risk, supplements may help
Beetroot juice outperforms nitrate supplements in boosting exercise performance
New treatment targeting aging cells could offer lasting relief for diabetic macular edema
Younger adults with atrial fibrillation face higher rates of heart failure and stroke
Anger damages blood vessel function, raising heart disease risk
Study reveals how long COVID can affect brain function through vascular disruption
Study suggests high levels of vitamin B3 breakdown products are linked to higher risk of mortality, heart attacks, and stroke
Space travel alters human vascular cell function, study finds

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
High testosterone levels in older men associated with greater risk of atrial fibrillation